|
HMGB3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.438600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.842300E-04 |
| Normal-vs-Stage2 |
2.216200E-02 |
| Normal-vs-Stage3 |
4.084100E-02 |
| Normal-vs-Stage4 |
7.299200E-01 |
| Stage1-vs-Stage2 |
5.085800E-01 |
| Stage1-vs-Stage3 |
7.996600E-01 |
| Stage1-vs-Stage4 |
1.294180E-01 |
| Stage2-vs-Stage3 |
4.665000E-01 |
| Stage2-vs-Stage4 |
8.233600E-02 |
| Stage3-vs-Stage4 |
2.079200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.008550E-04 |
| Normal-vs-AfricanAmerican |
5.317200E-01 |
| Normal-vs-Asian |
4.985600E-01 |
| Caucasian-vs-AfricanAmerican |
3.480600E-01 |
| Caucasian-vs-Asian |
2.066400E-01 |
| AfricanAmerican-vs-Asian |
9.848600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.389040E-04 |
| Normal-vs-Female |
8.320100E-03 |
| Male-vs-Female |
9.264100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.770400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.545230E-01 |
| Normal-vs-Age(61-80Yrs) |
1.898150E-02 |
| Normal-vs-Age(81-100Yrs) |
1.209570E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.091700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.342600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.797200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.856970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.399200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.714200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.282000E-01 |
| Classical-VS-Follicular |
1.332570E-01 |
| Classical-VS-Other |
7.012600E-01 |
| Classical-VS-Normal |
1.607340E-04 |
| Tall-VS-Follicular |
7.158600E-01 |
| Tall-VS-Other |
5.513600E-01 |
| Tall-VS-Normal |
2.514800E-01 |
| Follicular-VS-Other |
3.375200E-01 |
| Follicular-VS-Normal |
1.545560E-01 |
| Other-VS-Normal |
2.317000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.056300E-03 |
| Normal-vs-N1 |
1.177580E-01 |
| N0-vs-N1 |
8.052800E-01 |
|
|
